DE69916066T2 - Neue benzoxazole mit pde-hemmender wirkung - Google Patents

Neue benzoxazole mit pde-hemmender wirkung Download PDF

Info

Publication number
DE69916066T2
DE69916066T2 DE69916066T DE69916066T DE69916066T2 DE 69916066 T2 DE69916066 T2 DE 69916066T2 DE 69916066 T DE69916066 T DE 69916066T DE 69916066 T DE69916066 T DE 69916066T DE 69916066 T2 DE69916066 T2 DE 69916066T2
Authority
DE
Germany
Prior art keywords
compounds
formula
hydroxy
alkoxy
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69916066T
Other languages
German (de)
English (en)
Other versions
DE69916066D1 (de
Inventor
Wolf-Rüdiger Ulrich
Hermann Amschler
Thomas Bär
Dieter Flockerzi
Beate Schmidt
Ulrich Thibaut
Armin Hatzelmann
Hildegard Boss
Rolf Beume
Hans-Peter Kley
Dietrich Häfner
Thomas Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of DE69916066D1 publication Critical patent/DE69916066D1/de
Application granted granted Critical
Publication of DE69916066T2 publication Critical patent/DE69916066T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69916066T 1998-07-06 1999-06-26 Neue benzoxazole mit pde-hemmender wirkung Expired - Fee Related DE69916066T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98112469 1998-07-06
EP98112469 1998-07-06
PCT/EP1999/004451 WO2000001695A1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Publications (2)

Publication Number Publication Date
DE69916066D1 DE69916066D1 (de) 2004-05-06
DE69916066T2 true DE69916066T2 (de) 2005-02-24

Family

ID=8232222

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916066T Expired - Fee Related DE69916066T2 (de) 1998-07-06 1999-06-26 Neue benzoxazole mit pde-hemmender wirkung

Country Status (14)

Country Link
US (1) US6376485B1 (cg-RX-API-DMAC7.html)
EP (1) EP1095040B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002519423A (cg-RX-API-DMAC7.html)
AT (1) ATE263166T1 (cg-RX-API-DMAC7.html)
AU (1) AU761647B2 (cg-RX-API-DMAC7.html)
CA (1) CA2336894A1 (cg-RX-API-DMAC7.html)
DE (1) DE69916066T2 (cg-RX-API-DMAC7.html)
DK (1) DK1095040T3 (cg-RX-API-DMAC7.html)
ES (1) ES2219031T3 (cg-RX-API-DMAC7.html)
IL (1) IL140468A0 (cg-RX-API-DMAC7.html)
PT (1) PT1095040E (cg-RX-API-DMAC7.html)
SI (1) SI1095040T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000001695A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200100088B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
JP5529746B2 (ja) * 2007-11-21 2014-06-25 デコード ジェネティクス イーエイチエフ 炎症性疾患、心臓血管疾患及び中枢神経系障害を治療するための置換されたベンゾアゾールpde4阻害剤
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405633A (en) * 1982-03-01 1983-09-20 Usv Pharmaceutical Corporation Method of treatment of asthma
US4490373A (en) * 1983-05-20 1984-12-25 Usv Pharmaceutical Corporation Method of treating asthma
AU699489B2 (en) * 1994-10-12 1998-12-03 Euro-Celtique S.A. Novel benzoxazoles
ATE230404T1 (de) * 1995-05-18 2003-01-15 Altana Pharma Ag Cyclohexyldihydrobenzofurane
HK1000785A1 (en) * 1995-05-19 2006-06-30 Kyowa Hakko Kogyo Co., Ltd Oxygen-containing heterocyclic compounds

Also Published As

Publication number Publication date
US6376485B1 (en) 2002-04-23
DK1095040T3 (da) 2004-07-26
DE69916066D1 (de) 2004-05-06
JP2002519423A (ja) 2002-07-02
PT1095040E (pt) 2004-08-31
ES2219031T3 (es) 2004-11-16
ZA200100088B (en) 2002-05-06
AU4778699A (en) 2000-01-24
WO2000001695A1 (en) 2000-01-13
EP1095040B1 (en) 2004-03-31
CA2336894A1 (en) 2000-01-13
ATE263166T1 (de) 2004-04-15
EP1095040A1 (en) 2001-05-02
IL140468A0 (en) 2002-02-10
AU761647B2 (en) 2003-06-05
SI1095040T1 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
DE69822162T2 (de) Neue tetrazolderivate
EP0882021B1 (de) Neue phenanthridine
DE60310576T2 (de) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
EP0889886B1 (de) Neue in 6-position substituierte phenanthridine
DE69809754T2 (de) Substituierte 6-phenylphenanthridine
EP0828728B1 (de) Phenyldihydrobenzofurane
DE69719358T2 (de) Substituierte dihydrobenzofurane als pde-hemmstoffe
EP1075477B1 (de) Neue Benzonaphtyridin-N-oxide
DE69719778T2 (de) Benzonaphthyridine als bronchialtherapeutika
DE69717827T2 (de) Benzofuran-4-carboxamide
EP0828727B1 (de) Cyclohexyldihydrobenzofurane
EP1086096B1 (de) Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4
DE60019894T2 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
DE69817548T2 (de) Tetrazole derivate
EP1109810B1 (de) Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
DE69821530T2 (de) Dihydrobenzifurane
DE69808099T2 (de) Substituierte 6-alkylphenanthridine
DE60025327T2 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
EP0941226A1 (de) (2,3-dihydrobenzofuranyl)-thiazole als phosphodiesterasehemmer
DE60020079T2 (de) Phenanthridin-N-oxide mit PDE-IV-hemmender Wirkung
EP1095040B1 (en) New benzoxazoles with pde-inhibiting activity
DE60108758T2 (de) 6-heteroarylphenanthridine
EP0819688A1 (de) 4-substituierte Benzofurane
DE69717277T2 (de) Imidazopyridine
EP1075476B1 (de) Benzimidazole und oxazole

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE

8339 Ceased/non-payment of the annual fee